Tango Therapeutics to go public via merger with Boxer Capital-backed SPAC
Tango Therapeutics, a biotech company, has agreed to go public via a merger with BCTG Acquisition Corp, a blank check company backed by Boxer Capital.
Tango Therapeutics, a biotech company, has agreed to go public via a merger with BCTG Acquisition Corp, a blank check company backed by Boxer Capital.
Copyright PEI Media
Not for publication, email or dissemination